BioNTech SE BNTX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.72B | -1.97B | -1.45B | -1.26B | -633.26M |
| Total Depreciation and Amortization | 795.83M | 558.56M | 306.94M | 210.06M | 273.71M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 902.71M | 924.93M | 915.63M | 1.03B | -50.54M |
| Change in Net Operating Assets | -248.34M | 1.27B | 1.17B | 646.91M | 173.66M |
| Cash from Operations | -269.47M | 792.65M | 946.71M | 617.72M | -236.43M |
| Capital Expenditure | -242.21M | -245.50M | -212.76M | -197.76M | -195.18M |
| Sale of Property, Plant, and Equipment | 8.25M | 9.92M | 6.53M | 5.18M | 5.23M |
| Cash Acquisitions | 271.65M | 308.25M | 308.25M | 225.64M | -82.61M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 703.92M | -1.34B | -1.33B | -3.05B | 1.08B |
| Cash from Investing | 741.61M | -1.27B | -1.23B | -3.02B | 803.92M |
| Total Debt Issued | 135.80M | 82.90M | 45.10M | 6.70M | -- |
| Total Debt Repaid | -59.30M | -59.60M | -55.80M | -57.60M | -45.90M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -403.50M | -129.20M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00M | -2.00M | -2.00M | -2.00M | -- |
| Cash from Financing | -379.68M | -125.40M | -14.30M | -59.71M | -50.84M |
| Foreign Exchange rate Adjustments | -3.88M | -31.32M | -17.04M | -30.01M | -17.14M |
| Miscellaneous Cash Flow Adjustments | 44.60M | 31.38M | 35.38M | 8.16M | -18.45M |
| Net Change in Cash | 133.18M | -602.52M | -275.75M | -2.48B | 481.05M |